7-37133216-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_014800.11(ELMO1):​c.1105A>G​(p.Met369Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,459,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

ELMO1
NM_014800.11 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.13

Publications

0 publications found
Variant links:
Genes affected
ELMO1 (HGNC:16286): (engulfment and cell motility 1) This gene encodes a member of the engulfment and cell motility protein family. These proteins interact with dedicator of cytokinesis proteins to promote phagocytosis and cell migration. Increased expression of this gene and dedicator of cytokinesis 1 may promote glioma cell invasion, and single nucleotide polymorphisms in this gene may be associated with diabetic nephropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
ELMO1 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24811003).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELMO1NM_014800.11 linkc.1105A>G p.Met369Val missense_variant Exon 14 of 22 ENST00000310758.9 NP_055615.8 Q92556-1A4D1X5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELMO1ENST00000310758.9 linkc.1105A>G p.Met369Val missense_variant Exon 14 of 22 1 NM_014800.11 ENSP00000312185.4 Q92556-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD2 exomes
AF:
0.00000403
AC:
1
AN:
247964
AF XY:
0.00000746
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000888
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000206
AC:
3
AN:
1459186
Hom.:
0
Cov.:
30
AF XY:
0.00000276
AC XY:
2
AN XY:
725914
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33346
American (AMR)
AF:
0.00
AC:
0
AN:
44348
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26078
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39478
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85688
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53392
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1110800
Other (OTH)
AF:
0.00
AC:
0
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 05, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1105A>G (p.M369V) alteration is located in exon 14 (coding exon 13) of the ELMO1 gene. This alteration results from a A to G substitution at nucleotide position 1105, causing the methionine (M) at amino acid position 369 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
19
DANN
Benign
0.93
DEOGEN2
Benign
0.16
T;T;T
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.057
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.96
.;.;D
M_CAP
Benign
0.0039
T
MetaRNN
Benign
0.25
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.76
N;N;N
PhyloP100
1.1
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.5
N;N;N
REVEL
Benign
0.12
Sift
Benign
0.11
T;T;T
Sift4G
Benign
0.49
T;T;T
Polyphen
0.0
B;B;B
Vest4
0.20
MutPred
0.39
Loss of catalytic residue at V365 (P = 0.0218);Loss of catalytic residue at V365 (P = 0.0218);Loss of catalytic residue at V365 (P = 0.0218);
MVP
0.20
MPC
0.77
ClinPred
0.11
T
GERP RS
5.3
Varity_R
0.25
gMVP
0.51
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1392445899; hg19: chr7-37172821; API